phaseiiProf. Diego Calvisi (WG1 Leader), Guest Editor of a Special Issue on Diagnosis, Molecular Pathogenesis, and Targeted Therapies for Cholangiocarcinoma to be published on Journal of Clinical Medicine, invites COST Action members and co-workers to submit articles reporting on this important topic. Reviews or original articles dealing with the biochemical and molecular aspects associated with CCA diagnosis, molecular pathogenesis, and targeted therapies in the preclinical (experimental) and clinical setting are welcome. For more information, please check the following link.
Deadline for manuscript submissions: 31 December 2020.